POD1 AN ECONOMIC EVALUATION OF NOVOSEVEN IN THE MANAGEMENT OF HAEMOPHILIA PATIENTS WITH INHIBITORS IN SLOVAKIA
Nov 1, 2002, 00:00 AM
10.1016/S1098-3015(10)61516-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)61516-1/fulltext
Section Title :
Section Order :
324
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61516-1&doi=10.1016/S1098-3015(10)61516-1